History:
Chief Complaint:
Patient presents with blurred vision in the left eye.
History of Present Illness:
Patient reports the onset of blurred vision in the left eye approximately one week ago. The blurriness is intermittent, described as a 'shadow' across their vision, and is more pronounced in the morning. The severity is rated as a 4/10 on a pain scale. The character of the visual complaint is described as a 'shadow' across their vision.
Past Ocular History:
* No prior history of eye diseases or surgeries.
Medical History:
* Patient reports a history of hypertension, well-controlled with medication.
Medication History:
* Amlodipine 5mg daily.
Allergies:
* No known drug allergies.
Family Ocular History:
* Mother has a history of glaucoma.
Social History:
* Non-smoker. Drinks alcohol occasionally.
Examination:
Visual Acuity:
* Unaided: OD 20/20, OS 20/40
* Aided: OD 20/20 with correction, OS 20/25 with correction
* Pinholes: OD improves to 20/20, OS improves to 20/30
Intraocular Pressure:
* Tonometry: OD 16 mmHg, OS 18 mmHg
Anterior Segment:
* OD: Clear cornea, deep and quiet anterior chamber, reactive pupil.
* OS: Clear cornea, deep and quiet anterior chamber, reactive pupil.
Posterior Segment:
* OD: Optic disc appears healthy, no hemorrhages or exudates, normal cup-to-disc ratio. Macula flat.
* OS: Optic disc appears healthy, no hemorrhages or exudates, normal cup-to-disc ratio. Macula flat.
Additional Tests / Scans:
* Visual fields: Full to confrontation.
Assessment:
Patient presents with blurred vision in the left eye. The most likely diagnosis is early cataract formation, with a secondary differential diagnosis of mild macular degeneration.
Plan:
Treatments:
* Discussed the option of cataract surgery.
Follow-Up:
Patient to return in 6 months for a follow-up examination.
Patient Education:
* Discussed the diagnosis of early cataract formation and the potential for progression.
* Explained the treatment options, including observation and surgery.
Referrals:
* No referrals required at this time.
Date: 1 November 2024